ORIGINAL_ARTICLE
Urinary Stone Management During COVID-19 Pandemic
Nowadays, Coronavirus disease 2019 (COVID-19) is a major health problem worldwide. So, regarding the highly recommended homestay strategies for preventing COVID-19, the usual treatment platform for several diseases has changed. During self-quarantine, the urolithiasis treatment is completely different. However, we can suggest conservative treatment for three months during the COVID-19 outbreak, and after that, a reevaluation of the patient will be done. Thus, the operation could be chosen carefully based on the patient's and urologist’s preferences and the infection rate in that center.
http://www.transresurology.com/article_114217_342cf65bc73fd8ec9cecc34201f60a58.pdf
2020-02-10
1
3
10.22034/tru.2020.245645.1030
Urinary stone
urology
COVID-19
Pandemic
urolithiasis
Alimohammad
Fakhr Yasseri
yasseri_2006@yahoo.com
1
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Diana
Taheri
diana1380@yahoo.com
2
Department of Pathology, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
LEAD_AUTHOR
1. Lippi G, Henry BM, Bovo C, Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis. 2020 May 26;7(2):85-90.
1
2. WHO Coronavirus Disease (COVID-19) Dashboard. 2020. URL: https://covid19.who.int/.
2
3. C. Türk (Chair), A. Neisius, A. Petrik, C. Seitz, A. Skolarikos (Vice-chair), K. Thomas, N.F. Davis, J.F. Donaldson, R. Lombardo, N. Grivas, Y. Ruhayel, members of the EAU urolithiasis Guidelines Panel. EAU Guidelines on urolithiasis. Retrieved from: https://uroweb.org/guideline/urolithiasis/
3
ORIGINAL_ARTICLE
The Characteristics and Outcomes of Patients Treated with Percutaneous Nephrolithotomy According to the Preoperative Renal Function Levels
IntroductionThe principles of nephrolithiasis therapy in patients with chronic kidney disease are the same as in patients with normal kidneys. Percutaneous nephrolithotomy (PNL) is the standard treatment for patients with complex or large-volume upper urinary tract calculi. We reported the characteristics and outcomes of patients following percutaneous nephrolithotomy according to their preoperative renal function levels.MethodsData on 53 consecutive patients treated with percutaneous nephrolithotomy in this prospective cohort study in 6 months were collected. Patients were divided into 3 groups by estimated glomerular filtration rate (eGFR) including chronic kidney disease (CKD) stages 0, 1 and 2 (eGFR ≥ 60 mL/min/1.73 m2), stage 3 (eGFR = 30 to 59 mL/min/1.73 m2) and stages 4 and 5 (eGFR < 30 mL/min/1.73 m2).Results31 patients with CKD stages 0, 1, and 2, 17 with CKD stage 3, and 5 with stages 4 and 5 were followed up for at least three months. The mean eGFR before and after PNL was 80.1 vs. 85.9, 47.6 vs. 49.1, and 23.5 vs. 23.4 mL/min/1.73 m2 in the mild, moderate, and severe CKD groups, respectively. Based on the statistical analysis, eGFR in the mild group had significantly increased compared to the other groups, whereas there was no considerable difference between the moderate and severe groups.ConclusionsBy the removal of kidney stones, the progression of CKD may be halted. While significant improvement was observed in early-stage CKD, sometimes unexpected deterioration could occur in patients at the end stages of renal disease.
http://www.transresurology.com/article_114223_0fbcfc4b87d1e27b7de15fabaaff1c75.pdf
2020-02-12
4
8
10.22034/tru.2020.239119.1025
Nephrolithiasis
Renal Insufficiency
Chronic
nephrolithotomy
Percutaneous
Shahram
Shabaninia
shahram.shabaninia@gmail.com
1
Department of Urology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Seyed Reza
Yahyazadeh
r.yahyazadeh@gmail.com
2
Department of Urology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
Arman
Mousavi
arman.mousavi@gmail.com
3
Department of Urology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Amir
Kasaeian
akasaeian@tums.ac.ir
4
Hematology-Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
AUTHOR
1. Inanloo, S.H., Yahyazadeh, S.R., et al. Feasibility and Safety of Ultrasonography Guidance and Flank Position During Percutaneous Nephrolithotomy. J Urol.2018 Jul; 200(1):195-201.
1
2. Mehmet, N.M., Ender, O. Effect of urinary stone disease and its treatment on renal function. World J Nephrol. 2015 May;4(2):271-6.
2
3. Etemadian, M., Maghsoudi, R., et al. Outcome of tubeless percutaneous nephrolithotomy in patients with chronic renal insufficiency. Iran J Kidney Dis. 2012 May;6(3):216-8.
3
4. Sairama, K., Scoffone, C.M., et al. Percutaneous Nephrolithotomy and Chronic Kidney Disease: Results from the CROES PCNL Global Study. J Urol. 2012 Oct; 188(4):1195-200.
4
5. Bilen, C.Y., Inci, K., et al. Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol. 2008 May; 22(5):895-900..
5
6. Kurien, A., Baishya, R., et al. The impact of percutaneous nephrolithotomy in patients with chronic kidney disease. J Endourol. 2009 Sep; 23(9):1403-7.
6
7. Levey, A.S., Coresh, J., et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate. Ann Intern Med.; 145:247–254.
7
8. Mishra, S., Sinha, L., et al. Renal deterioration index: a preoperative prognostic model for renal functional outcome after treatment of bilateral obstructive urolithiasis in patients with chronic kidney disease. J Endourol. 2013 Nov; 27(11):1405-10.
8
9. Ozden, E., Mercimek, M.N., et al. Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology. 2012 May; 79(5):990-4.
9
10. Akman, T., Binbay, M., et al. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single-center experience. J Urol. 2012 Jan; 187(1):173-7.
10
ORIGINAL_ARTICLE
Cornus Mas and Urinary Tract Infections Treatment
Urinary tract infections (UTIs) are complicated to treat, and patients frequently will have the problem of infection recurrence after a complete cure. Usually, UTI treatment is done by antibiotics, but the problem of bacterium resistance and sensitivity should always be kept in mind. The recent trends in herbal medicine open new insight into cranberry (Cornus mas) as a promising anti-infection and anti-cancer substance. It has shown anti-infection properties in UTIs, especially for thoroughly treating recurrent urinary tract infections. However, it can increase the risk of kidney stones and interaction with warfarin.
http://www.transresurology.com/article_117640_8f88331a907dd37c9d6e4c8e17d69ce0.pdf
2020-02-15
9
11
10.22034/tru.2020.245624.1028
Urinary tract infections
Herbal medicine
Cornus Mas
Fatemeh
Khatami
fatemehkhatami1978@gmail.com
1
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Fateme
Guitynavard
f_guitynavard@ymail.com
2
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
1. Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World Journal of Urology. 2020:1-11.
1
2. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. The American journal of medicine. 2002;113(1):35-44.
2
3. Naber KG, Wullt B, Wagenlehner FM. Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women. International journal of antimicrobial agents. 2011;38:21-35.
3
4. Weh K, Clarke J, Kresty L. Cranberries and cancer: An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents. Antioxidants. 2016;5(3):27.
4
5. Jensen HD, Struve C, Christensen SB, Krogfelt KA. Cranberry juice and combinations of its organic acids are effective against experimental urinary tract infection. Frontiers in microbiology. 2017;8:542.
5
6. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF, Koropatnick J. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutrition and cancer. 2006;56(1):86-94.
6
7. Jensen HD, Struve C, Christensen SB, Krogfelt KA. Cranberry Juice and Combinations of Its Organic Acids Are Effective against Experimental Urinary Tract Infection. Front Microbiol. 2017;8:542.
7
8. Asma B, Vicky L, Stephanie D, Yves D, Amy H, Sylvie D. Standardised high dose versus low dose cranberry Proanthocyanidin extracts for the prevention of recurrent urinary tract infection in healthy women [PACCANN]: a double blind randomised controlled trial protocol. BMC Urol. 2018;18(1):29-.
8
9. Asma B, Vicky L, Stephanie D, Yves D, Amy H, Sylvie D. Standardised high dose versus low dose cranberry Proanthocyanidin extracts for the prevention of recurrent urinary tract infection in healthy women [PACCANN]: A double blind randomised controlled trial protocol. BMC Urol. 2018;18(1):29.
9
10. Sengupta K, V Alluri K, Golakoti T, V Gottumukkala G, Raavi J, Kotchrlakota L, et al. A randomized, double blind, controlled, dose dependent clinical trial to evaluate the efficacy of a proanthocyanidin standardized whole cranberry (Vaccinium macrocarpon) powder on infections of the urinary tract. Current Bioactive Compounds. 2011;7(1):39-46.
10
11. Walker RP, Famiani F. Organic acids in fruits: metabolism, functions and contents. Hort Rev. 2018;45:371-430.
11
ORIGINAL_ARTICLE
A Case Report of Electric Wire as Foreign Body in Urinary Bladder
IntroductionThere are reports that various foreign bodies were inserted into urogenital tracts, and urologists have been facing this issue for many years. Foreign bodies in the bladder may be attributed to self-infliction, iatrogenic issues, or migration from other adjacent organs. In children, curiosity and playfulness may be the primary motives for inserting objects into the urethra.Case Presentations Here, a case report of a 19-year-old boy who inserted a wire (telephone cable) into his bladder is presented. Under general anesthesia, the cystoscopy was performed and using grasper the cable was removed from the bladder of the patient. He was discharged a day after with just a few irritative symptoms. At the time of discharge, the patient’s parents were advised for psychiatric consultation.ConclusionsThe foreign body of the bladder in patients can happen in a patient with a mental health disorder. To diagnose through pelvic radiograph plays a crucial role in the diagnosis of the disease.
http://www.transresurology.com/article_117643_2b3264eb9c0ead7ce570d0b70755e541.pdf
2020-02-18
12
16
10.22034/tru.2020.246031.1032
Bladder
Foreign body
lower urinary tract symptoms
Fateme
Guitynavard
f_guitynavard@ymail.com
1
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Seyed Saeed
Tamehri Zadeh
tamehrysaeed@gmail.com
2
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Mehdi
Naghdipoor Farhadabad
naghdipoormehdi@gmail.com
3
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Maryam
Gholamnejad
mary_medical86@yahoo.com
4
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Mohammad Mehdi
Rakebi
m_rakebi@yahoo.com
5
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Seyed Mohammad Kazem
Aghamir
mkaghamir@tums.ac.ir
6
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
LEAD_AUTHOR
1. Moon SJ, Dai Hee Kim JHC, Jo JK, Son YW, Choi HY, Moon HS. Unusual foreign bodies in the urinary bladder and urethra due to autoerotism. International neurourology journal. 2010;14(3):186.
1
2. Rahman NU, Elliott SP, McAninch JW. Self‐inflicted male urethral foreign body insertion: Endoscopic management and complications. BJU international. 2004;94(7):1051-3.
2
3. Van Ophoven A, DE KERNION JB. Clinical management of foreign bodies of the genitourinary tract. The Journal of urology. 2000;164(2):274-87.
3
4. OSCA JM, Broseta E, Server G, RUIZ JL, Gallego J, Jimenez‐Cruz J. Unusual foreign bodies in the urethra and bladder. British journal of urology. 1991;68(5):510-2.
4
5. Trehan RK, Haroon A, Memon S, Turner D. Successful removal of a telephone cable, a foreign body through the urethra into the bladder: a case report. Journal of medical case reports. 2007;1(1):153.
5
6. Barzilai M, Cohen I, Stein A. Sonographic detection of a foreign body in the urethra and urinary bladder. Urologia Internationalis. 2000;64(3):178-80.
6
7. Bansal A, Yadav P, Kumar M, Sankhwar S, Purkait B, Jhanwar A, et al. Foreign bodies in the urinary bladder and their management: a single-centre experience from North India. International neurourology journal. 2016;20(3):260.
7
8. Kenney RD. Adolescent males who insert genitourinary foreign bodies: is psychiatric referral required? Urology. 1988;32(2):127-9.
8
9. Khan A, Kaiser C, Dailey B, Krane R. Unusual foreign body in the urethra. Urologia internationalis. 1984;39(3):184-6.
9
10. Abdulla M. Foreign body in the bladder. British journal of urology (Print). 1990;65(4):420-.
10
11. Rosenblatt P, Pulliam S, Edwards R, Boyles SH. Suprapubically assisted operative cystoscopy in the management of intravesical TVT synthetic mesh segments. International Urogynecology Journal. 2005;16(6):509-11.
11
12. Eckford S, Persad R, Brewster S, Gingell J. Intravesical foreign bodies: five‐year review. British journal of urology. 1992;69(1):41-5.
12
13. Huang W-C, Yang J-M. Sonographic appearance of a bladder calculus secondary to a suture from a bladder neck suspension. Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine. 2002;21(11):1303.
13
14. Lazar J, Asrani A. Sonographic diagnosis of a glass foreign body in the urinary bladder. Journal of ultrasound in medicine. 2004;23(7):969-71.
14
15. Pal DK, Bag AK. Intravesical wire as foreign body in urinary bladder. International braz j urol. 2005;31(5):472-4.
15
ORIGINAL_ARTICLE
A Review of Animal Laboratory Practice in the COVID-19 and Safety Concerns
The research in biomedical sciences is based on primary research on animals. Due to the coronavirus disease-2019 (COVID-19) pandemic, many research projects involving animal studies have faced interruptions due to the raised concerns about the safety of working with animals The disruption in such research projects has raised significant concerns in biomedical scientific research worldwide. Assessing and evaluating the safety and feasibility of research projects on animal models seems necessary. This study provides evidence of the feasibility of continuing research activities in animal laboratories during the COVID-19 pandemic. According to the results of studies, the risk of COVID-19 is low in routine laboratory animals, including mice, rats, and pigs.By examining the available data from our animal laboratory and continuing research activities on low-risk animals, with adequate safety and personal protective equipment available at the facility, animal studies could be carried forward without endangering the safety of the researcher and society.
http://www.transresurology.com/article_118063_aae6a1c382745657b5ac97c16b86acc2.pdf
2020-02-21
17
21
10.22034/tru.2020.249149.1033
Coronavirus
Animal laboratory
Biomedical Research
COVID-19
Rahil
Mashhadi
rh_mashhadi@yahoo.com
1
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Fatemeh
Khatami
fatemehkhatami1978@gmail.com
2
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Leyla
Zareian Baghdadabad
l_zareian@farabi.tums.ac.ir
3
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Alireza Namazi
Shabestari
namazialireza109@yahoo.com
4
Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Fateme
Guitynavard
f_guitynavard@ymail.com
5
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
Leonardo
Oliveira Reis
loliveirareis98@gmail.com
6
UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, São Paulo, Brazil
LEAD_AUTHOR
1. Baumans V. Baumans, V. Science-based assessment of animal welfare: laboratory animals. Rev. Sci. Tech. 24, 503-513. Revue scientifique et technique (International Office of Epizootics). 2005;24:503-13.
1
2. Brown P. A Word from OLAW: COVID-19 guidance. Lab Animal. 2020;49(5):132-.
2
3. Kruse H, kirkemo A-M, Handeland K. Wildlife as source of zoonotic infections. Emerg Infect Dis. 2004;10(12):2067-72.
3
4. Centers for Disease Control and Prevention. COVID-19 and Animals 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/animals.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fanimals.html.
4
5. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
5
6. World Organisation for Animal Health. Questions and Answers on the 2019 Coronavirus Disease (COVID-19) 2020. Available from: https://www.oie.int/en/scientific-expertise/specific-information-and-recommendations/questions-and-answers-on-2019novel-coronavirus/.
6
7. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-2014; The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264-6.
7
8. Parry NMA. COVID-19 and pets: When pandemic meets panic. Forensic Science International: Reports. 2020;2:100090-.
8
9. Agriculture Fisheries and Conservation Department (AFCD). Detection of low level of COVID-19 virus in pet dog. 2020 [Available from: https://www.afcd.gov.hk/english/publications/publications_press/pr2342.html.
9
10. Almendros A. Can companion animals become infected with Covid-19? Vet Rec. 2020;186(12):388-9.
10
11. PRO/AH/EDR>COVID-19 update (45). China (Hong Kong) animal, dog, 2nd case PCR Positive. 2020.
11
12. Leroy EM, Ar Gouilh M, Brugère-Picoux J. The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic. One Health. 2020:100133.
12
13. SciCoM - Comite Scientifique de l’Institué auprès de l’Agence Fédérale pour la Sécurité de la Chaîne Alimentaire. Risque zoonotique du SARS-CoV2 (Covid-19) associé aux animaux de compagnie: infection de l’animal vers l’homme et de l’homme vers l’animal. 2020.
13
14. United States Department of Agriculture AaPHIS. USDA Statement on the Confirmation of COVID-19 in a Tiger in New York 2020 [Available from: https://www.aphis.usda.gov/aphis/newsroom/news/sa_by_date/sa-2020/ny-zoo-covid-19.
14
15. Quartz daily brief. How monkeys, ferrets, and horses are helping scientists fight Covid-19 2020 [Available from: https://qz.com/1837094/how-lab-animals-are-helping-scientists-fight-covid-19/.
15
16. Max Planck Institute for Developmental Biology. Number of laboratory animals in Germany 2009 [Available from: http://www.eb.tuebingen.mpg.de/research/animal-research/laboratory-animals-and-animal-welfare/numbers-laboratory-animals-in-germany.html.
16
17. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-80.e8.
17
18. Chan JF-W, Zhang AJ, Yuan S, Poon VK-M, Chan CC-S, Lee AC-Y, et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clinical Infectious Diseases. 2020.
18
19. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62.
19
ORIGINAL_ARTICLE
Effect of Modified Vacuum in Patients with Peyronie’s Disease and Erectile Dysfunction
IntroductionPeyronie's disease (PD) is a penile disease that is characterized by penile pain, curvature, shortening, and plaque in the penis, which usually ends up in erectile dysfunction (ED). This study assesses the efficacy of modified vacuum therapy in patients with PD and ED. The basic principle of the study is similar to modeling performed during penile implant surgery. MethodsThis study was performed on 43 Patients who practiced with three different vacuum cylinders for 30 minutes, 3 times a day for 3 months. First, the second and third months with the smallest, medium, and biggest cylinders were used, respectively. Parameters were recorded before the beginning of the study at the end of each month. Assessment includes the number and size of the plaque, angle of penile curvature (by erection induced with vacuum constriction device (VCD)), pain during erection, the status of morning erection, quality of an erection, and various previous treatments. There was a clinically and statistically significant improvement in the angle of curvature, size, and number of plaques. ResultsA total of 43 patients with a mean age of 56.3 years(40-74) participated in the study. There was a significant reduction in plaque size and curvature. The mean of plaque size and curvature was 1.39cm and 31.28 degrees, respectively, at the presentation, which was reduced to 0.64 (0-3)cm and 11.6 degrees, respectively, at the study's end. At the end of the study, 30(69.7%) patients were satisfied with the outcome and wanted no further treatment. There was no significant side effect observed in patients using the device. ConclusionsWe recommend using a modified vacuum device with the mentioned method for PD and ED with curvature less than 45 degrees and plaque size less than 2cm. It is safe to use in all stages of the disease and can help patients to attain erection with VCD.
http://www.transresurology.com/article_118590_dd8d96b11e7e91e7f81afa7bf4c2f0bd.pdf
2020-02-24
22
27
10.22034/tru.2020.237420.1024
Peyronie’s Disease
penile curvature
penile plaque
Erectile Dysfunction
Vacuum pump therapy
Amir
Ghasemlouei
ghasemloeeamir@yahoo.com
1
Medical Department, General Surgery Resident of Tehran University of Medical Science,Tehran,Iran
LEAD_AUTHOR
Feraidoon
Khayyamfar
khayyamfar@gmail.com
2
Urology Ward, Mostafakhomeini Hospital,Shahed University of Medical Science, Tehran, Iran
AUTHOR
Seyed Kazem
Foroutan
foroutan@shahed.ac.ir
3
Urology Ward, Mostafakhomeini Hospital,Shahed University of Medical Science, Tehran, Iran
AUTHOR
Mostafa
Rajabi
rajabi_mostafa@yahoo.com
4
Medical Department,General Surgeon,Isfahan University of Medical Science,Isfahan,Iran
AUTHOR
1. Kadioglu, A., et al., Surgical treatment of Peyronie’s disease: a critical analysis. European urology, 2006. 50(2): p. 235-248.
1
2. Qian, A., et al., Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology, 2004. 64(2): p. 399-404.
2
3. Lin, H., C. Liu, and R. Wang, Effect of penile traction and vacuum erectile device for Peyronie’s disease in an animal model. The Journal of Sexual Medicine, 2017. 14(10): p. 1270-1276.
3
4. Schwarzer, U., et al., The prevalence of Peyronie's disease: results of a large survey. BJU international, 2001. 88(7): p. 727-730.
4
5. Mulhall, J.P., et al., Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. The Journal of urology, 2004. 171(6 Part 1): p. 2350-2353.
5
6. Weidner, W., et al., Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. The Journal of urology, 1997. 157(1): p. 325-328.
6
7. Mulcahy, J. and S. Wilson, Management of Peyronie's disease with penile prostheses. International journal of impotence research, 2002. 14(5): p. 384-388.
7
8. Raheem, A., et al., THE ROLE OF VACUUM THERAPY TO MECHANICALLY STRAIGHTEN THE PENIS IN PEYRONIE'S DISEASE: UP-034. The Journal of Sexual Medicine, 2009. 6.
8
9. LaRochelle, J.C. and L.A. Levine, PEYRONIE'S DISEASE: A Survey of Primary-Care Physicians and Urologists Regarding Peyronie's Disease. The journal of sexual medicine, 2007. 4(4): p. 1167-1173.
9
10. Russell, S., W. Steers, and K.T. McVary, Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease. European urology, 2007. 51(3): p. 640-647.
10
11. Levine, L.A., Seeking answers on the quest for effective nonsurgical treatment of Peyronie's disease.European urology, 2007. 3(51): p. 601-603.
11
12. Anaissie, J. and F.A. Yafi, A review of surgical strategies for penile prosthesis implantation in patients with Peyronie’s disease. Translational andrology and urology, 2016. 5(3): p. 342.
12
13. Mulhall, J.P., J. Schiff, and P. Guhring, An analysis of the natural history of Peyronie’s disease. The Journal of urology, 2006. 175(6): p. 2115-2118.
13
14. Yuan, J., et al., Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study.European urology, 2010. 58(5): p. 773-780.
14
15. Broderick, G.A., et al., The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. The Journal of urology, 1992. 147(1): p. 57-61.
15
ORIGINAL_ARTICLE
Unusual Complication of Ewing Sarcoma of Vulva: Case Report
IntroductionPrimary Ewing sarcoma of the vulva is an extremely rare tumor with less than 10 molecular confirmed reported cases. Urinary retention in this case is an unusual manifestation. Case presentationWe describe a 15 years-old female patient with advanced Ewing sarcoma of the vulva and urinary retention during chemotherapy. The technique of catheterization with two catheters could be interesting, in this case as well. When it comes to Immunohistochemistry, tumor cells displayed CD99, NIKX2. ConclusionsIn all cells and proliferative capacity of KI-67 in 40% of tumor cells, but other markers were negative.
http://www.transresurology.com/article_118963_d0a838d39bba4b7fb26e4696e968843e.pdf
2020-02-24
28
31
10.22034/tru.2020.255363.1039
Sarcoma
Ewing
Vulva Neoplasms
Vulva
Urinary retention
Masoud
Khalil
wwwmkh@yahoo.com
1
Department of Urology, Velayat Hospital, Gazvin University of Medical Sciences, Gazvin, Iran
LEAD_AUTHOR
Parsa
Yousefichaijan
parsayousefichaijan@yahoo.com
2
Clinical Research Development Center of Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran
AUTHOR
Alimohammad
Fakhr Yasseri
yasseri_2006@yahoo.com
3
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
AUTHOR
1. Rekhi B, Chinnaswamy G, Vora T, Shah S, Rangarajan V. Primary Ewing sarcoma of vulva, confirmed with molecular cytogenetic analysis: A rare case report with diagnostic and treatment implications. Indian J Pathol Microbiol. 2015;58(3):341-4.
1
2. Boldorini R, Riboni F, Cristina S, Allegrini S, Valentini S, Muscarà M, et al. Primary vulvar Ewing’s sarcoma/primitive neuroectodermal tumor in a post-menopausal woman: a case report. Pathol Res Pract. 2010;206(7):476-9.
2
3. Matsuda M, Ichimura T, Kasai M, Murakami M, Hoshi M, Kawamura N, et al. Primitive neuroectodermal tumor originating in the vulva: A case report. Oncol Lett. 2014;8(1):187-9.
3
4. El Housheimi A, Khalil A, Khalifeh D, Berjawi G, Seoud M, Tabbarah A, et al. Primary vulvar Ewing sarcoma/peripheral primitive neuroectodermal tumor with pelvic lymph nodes metastasis: A case report and review of literature. Journal of Obstetrics and Gynaecology Research. 2020.
4
5. Takenaka S, Naka N, Obata H, Joyama S, Hamada K-I, Imura Y, et al. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma. Japanese journal of clinical oncology. 2016;46(6):522-8.
5
6. Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registry. Cancer. 2010;116(8):1964-73.
6
7. Babu MS, Sreevalli A, Thottian AGF, Suma M, Lokanatha D, Jacob LA, et al. Ewing’s sarcoma of the vulva: An uncommon tumor in an uncommon site. Indian Journal of Medical and Paediatric Oncology. 2020;41(3):397.
7